ArticleAnnals of surgical oncology2026
Patients' Lived Experiences After Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis from GI Malignancies: A Qualitative Study.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent literature on quality of life (QOL) after cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) demonstrates that most patients have a temporary decline in QOL with a return to baseline 3-12 months postoperatively. This qualitative study aimed to explore patient perceptions of QOL and to understand how adaptation influences their experiences.
methodsThe study involved 1 h semi-structured interviews with patients who underwent CRS/HIPEC for non-low-grade appendiceal mucinous neoplasm lower gastrointestinal (GI) pathology from May 2023 to March 2024. The interview guide focused on patients' QOL after CRS/HIPEC, with a focus on patient adaptation. Interview transcripts were analyzed using the constant comparative method to identify recurrent themes.
resultsOf 18 patients, 14 participated (median age, 57; 50 % women) a median of 16.9 months after surgery. The study identified 6 major themes and 19 subthemes. The six major themes were low baseline QOL, hope, emotional QOL, physical QOL, a "new normal," and response shift. Most participants described low QOL before CRS/HIPEC, hope upon learning about this treatment, and variable recovery experiences. Fatigue and long-term limitations on functional status were common, leading to inability to work and social isolation. Most patients accepted this new baseline QOL and adapted to it. DISCUSSION: Patients undergoing CRS/HIPEC often have persistent physical and emotional impacts on QOL. These often improve over time as patients adapt to their new baseline QOL. These findings highlight the importance of addressing functional status and its impacts with CRS/HIPEC patients. In addition, future QOL research should account for the effects of response shift.
Indexed as
Identifiers
41866573What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.